27 November 2005

Oral Vitamin D for Kidney Patients



Abbot Labs: Zemplar. Oral form approved for Stage 3 and 4 chronic kidney disease/ESRD. Previous injectable version was for dialysis patients only. Looks like it is specific for secondary hyperparathyroidism.

http://www.abbottrenalcare.com/002zemplar.html: "Rapidly suppresses PTH with no significant difference in the incidence of hyperphosphatemia or hypercalcemia."

This may be a good ticket even for very long-term post-transplant calcium/vitamin D metabolism problems.